Editorial
Managing Thrombosis in Polycythemia Vera: The Advanced Practitioner Perspective
Lindsey Lyle, MS, PA-C, Guest Editor
Grand Rounds
Budd-Chiari Syndrome as Initial Manifestation of Polycythemia Vera: Complexities in the Management of Younger Patients
Lindsey Lyle,(1) MS, PA-C, and Lindsey E. Kalhagen,(2) PA
Grand Rounds
Optimizing Treatment Strategies in Patients With Polycythemia Vera Who Develop a Thrombotic Event on Frontline Therapy
Lindsey Lyle,(1) MS, PA-C, and Julie Huynh-Lu,(2) PA
Editorial
The Advanced Practitioner’s Role in Treating Older Adults With Hematologic Malignancies
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Meeting Abstract
ASH Highlights and Commentary: Chronic Lymphocytic Leukemia

Meeting Abstract
ASH Highlights and Commentary: Acute Myeloid Leukemia and Myelodysplastic Syndromes

Meeting Abstract
ASH Highlights and Commentary: Multiple Myeloma

Editorial
Acute Myeloid Leukemia: An Ever-Changing Disease
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Review Article
Optimizing Use of Newly Approved Agents for Acute Myeloid Leukemia
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Review Article
The Role of the Advanced Practitioner in Enhancing Outcomes
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Appendix
Appendix: Key Information on Newly Approved AML Drugs
Nancy M. Nix, PharmD, BCPS, BCOP, and Allyson Price, MPAS, PA-C
Editorial
CAR T-Cell Therapy for Large B-Cell Lymphoma
Maritza C. Alencar, DNP, MBA, APRN-BC, BMTCN®
Review Article
Anti-CD19 CAR T-Cell Therapy for Adult Patients With Refractory Large B-Cell Lymphoma
Kathleen McDermott, RN, BSN, OCN®, BMTCN®, and Lauren Spendley, AGNP, MSN, AOCN®
Review Article
CAR T-Cell Therapy: Adverse Events and Management
Sherry Adkins, RN, MSN, ANP-C
Review Article
Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-Cell Therapy
Alix Beaupierre, RN, BSN, OCN®, Nicole Kahle, MS, RN, OCN®, BMTCN®, Rachel Lundberg, PA-C, MPAS, and Amy Patterson, MSN, APRN, AOCNS®, BMTCN®
Editorial
A Letter From the Guest Editor
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Commentary
ASH Highlights and Commentary: Multiple Myeloma
Josh Epworth, ARNP
Commentary
ASH Highlights and Commentary: Acute Myeloid Leukemia
Lindsey Lyle, MS, PA-C
Commentary
ASH Highlights and Commentary: Leukemias and Lymphomas
Sandra E. Kurtin, PhD, ANP-C, AOCN®
Editorial
Immuno-Oncology Essentials: An Overview
Brianna Hoffner, MSN, ANP-BC, AOCNP®
Review Article
Meeting the Challenge of Immune-Related Adverse Events With Optimized Telephone Triage and Dedicated Oncology Acute Care
Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Krista M. Rubin, MS, FNP-BC
Review Article
PD-1/PD-L1 Inhibitors for Non–Small Cell Lung Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP®
Review Article
Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management
Casey Fazer, PA-C
Review Article
Immune-Related Adverse Events From Immunotherapy: Incorporating Care Step Pathways to Improve Management Across Tumor Types
Laura S. Wood, RN, MSN, OCN®
Appendix
Care Step Pathway Tools for Immune-Related Adverse Event Assessment and Management

Editorial
A Letter From the Guest Editors
Lisa A. Kottschade, APRN, MSN, CNP, and LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP
Editorial
A Brighter Future for Patients With Melanoma
Lisa A. Kottschade, APRN, MSN, CNP, and LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP
Review Article
Diagnosis, Evaluation, and Surgical Management of Melanoma
Brianna Hoffner, MSN, ANP-BC, AOCNP®, and Christan G. Bartsch, MSHS, PA-C, MPH
Review Article
Harnessing the Immune System in the Treatment of Melanoma
Suzanne McGettigan, MSN, CRNP, AOCN®
Review Article
BRAF/MEK Inhibition in Melanoma: An Update
Lisa A. Kottschade, APRN, MSN, CNP, and Kathleen M. Madden, RN, MSN, FNP-BC, AOCNP®, APHN
Review Article
Mutations Beyond BRAF V600
Mollie Reed, MSN, ACNP-BC
Review Article
Melanomas of Noncutaneous Origin: Diagnosis, Treatment, and Outcomes
Lisa A. Kottschade, APRN, MSN, CNP
Review Article
Supportive Care and Management of Treatment-Related Adverse Effects From Immune Checkpoint Inhibitors and Targeted Therapies in Melanoma
Krista M. Rubin, MS, FNP-BC, and Lisa A. Kottschade, APRN, MSN, CNP
Review Article
Drug-Drug Interactions in Melanoma
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP
Appendix
Appendix
Compiled by Lisa A. Kottschade, APRN, MSN, CNP
Editorial
A Letter From the Guest Editors
Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP
Continuing Education
Chronic Lymphocytic Leukemia in 2018: What the Advanced Practitioner in Oncology Needs to Know
Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP
Review Article
Scientific Advances in the Diagnosis and Risk Stratification of Chronic Lymphocytic Leukemia
Amy Goodrich, MSN, CRNP, and Nina Wagner-Johnston, MD
Review Article
Monoclonal Antibodies in Chronic Lymphocytic Leukemia
Lindsay Hladnik,(1) PharmD, BCOP, Kristan Augustin,(2) PharmD, BCOP, and Christopher Arp,(3) PharmD
Review Article
Small Molecules in Chronic Lymphocytic Leukemia: Novel Targets, New Challenges
Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP
Review Article
Emerging Therapies in Chronic Lymphocytic Leukemia: Current Trials
Ashley E. Glode, PharmD, BCOP, and Hani M. Babiker, MD
Review Article
Risk-Adapted Treatment Strategies for Chronic Lymphocytic Leukemia
Lisa Nodzon, PhD, ARNP, AOCNP®, and Javier Pinilla-Ibarz, MD, PhD
Review Article
Supportive Care and Management of Treatment-Emergent Adverse Events in Chronic Lymphocytic Leukemia
Barbara Barnes Rogers, CRNP, MN, AOCN®, ANP-BC, and Nadia Khan, MD
Review Article
The Older Adult Living With Chronic Lymphocytic Leukemia: Implications for Oncology Providers, Patients, and Caregivers
Sandra E. Kurtin, PhDc, ANP-C, AOCN®
Appendix
Appendix
Compiled by Ali McBride, PharmD, BCOP, Andrew Garcia, PharmD, and Alyssa Hinchman, PharmD
Editorial
A Letter From The Guest Editor

Review Article
The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics
Kimberly M. Hicks,(1) PharmD, MHA, Diane Cope,(2) PhD, ARNP-BC, AOCNP®, John Novak,(3) CHA, PA-C, and Susan Scherer,(4) RN, BSN, OCN
Editorial
The Rise of Genetic Testing in Managing Patients With Ovarian Cancer
Patrick J. Kiel, PharmD, BCPS, BCOP
Review Article
The Emerging Role of Molecular Testing in Ovarian Cancer
Patrick J. Kiel,(1) PharmD, BCPS, BCOP, Courtney B. Cortez,(2) NP, Cynthia L. Hunter,(3) MS, LCGC, and Jeanne M. Schilder,(1) MD
Editorial
The Rise of Genetic Testing in Managing Patients With Non–Small Cell Lung Cancer
Patrick J. Kiel, PharmD, BCPS, BCOP
Review Article
The Emerging Role of Molecular Testing in Non–Small Cell Lung Cancer
Patrick J. Kiel,(1),(2) PharmD, BCPS, BCOP, Liang Cheng,(1) MD, Anna Livers-Ertel,(3) ANP-BC, MSN, OCN®, and Gregory Durm,(2) MD
Editorial
Introduction
Heather Hampel, MS, LGC, Guest Editor
Review Article
Lynch Syndrome and Immunotherapy
Heather Hampel, MS, LGC, and Brianna Hoffner, MSN, ANP-BC, AOCNP®
Review Article
BRCA-Related Ovarian Cancers and the Role of PARP Inhibitor Therapy
Leigha Senter, MS, LGC, and Paula Anastasia, RN, MN, AOCN®
Continuing Education
CAR T-Cell Therapy: An Approach Whose Time Has Come

Continuing Education
The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias
Marco L. Davila, MD, PhD
Editorial
Letter From the Guest Editors

Editorial
Take a Deep Breath: More Treatment Options for Non–Small Cell Lung Cancer
Lisa Cordes, PharmD, BCACP, BCOP, and Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
Review Article
Diagnosis of Lung Cancer
Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®, and Helen Shih, MSN, MPH
Review Article
Fundamentals of Lung Cancer Staging
Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®
Review Article
Predictive and Prognostic Biomarkers and Related Therapies in Non–Small Cell Lung Cancer
Samantha Schmidt, PharmD, and Grashma Vadakkel, PharmD(c)
Review Article
Supportive Care and Management of Treatment-Emergent Adverse Events With Targeted Therapy in Non–Small Cell Lung Cancer
Clell Hasenbank, PharmD
Review Article
Emerging Biomarkers in Non–Small Cell Lung Cancer
Melinda Oliver, BA, BSN, RN, MPAP
Review Article
Immunotherapy Mechanisms of Action in Non–Small Cell Lung Cancer
Beth Eaby-Sandy, MSN, CRNP, OCN®
Review Article
Unleashing the Immune System With Checkpoint Inhibitors in Non–Small Cell Lung Cancer: Clinical Review of Adverse Events
Sandra Cuellar, PharmD, BCOP
Review Article
Emerging Therapies in Non–Small Cell Lung Cancer: Clinical Trials With Novel Agents
Karen Oishi, MSN, APRN, AGPCNP-BC, OCN®
Tools and Technology
Resources for Patients With Non–Small Cell Lung Cancer and Their Caregivers and Providers
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC
Appendix
Appendix
Lisa Cordes, PharmD, BCACP, BCOP
Editorial
Priming the Pump Task Force

Continuing Education
Continuing Education Information

Continuing Education
Meet the Team

Continuing Education
Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model
Angela DeMichele, MD, MSCE; Jennie Greco Lattimer, MSN, BSN, CRNP; and Rachel F.
Appendix
Appendix
Managing the Care of Patients With HER2-Positive Breast Cancer: A Collaborative Practice Model
Continuing Education
Continuing Education Information

Editorial
The Future is Bright
Sandra Kurtin, RN, MSN, AOCN®, ANP-C
Editorial
The Continuum of Care in Multiple Myeloma Redefined: Challenges and Opportunities
Sandra Kurtin, RN, MSN, AOCN®, ANP-C, Guest Editor
Review Article
Sequencing of Treatment and Integration of Clinical Trials
Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, Charise Gleason,(2) MSN, NP-BC, AOCNP®, Kathleen Colson,(3) RN, BSN, BS, Ann McNeill,(4) RN, MSN, APN, and Donna Catamero,(5) ANP-BC, OCN®, CCRC, on behalf of the International Myeloma Foundation Nurse Leadership Board
Review Article
Palliative Care in Multiple Myeloma
Tiffany Richards,(1) MS, ANP, AOCNP®, and Kevin Brigle,(2) PhD, NP, on behalf of the International Myeloma Foundation Nurse Leadership Board
Prescriber's Corner
New Agents in the Treatment of Multiple Myeloma
Beth Faiman,(1) PhD, MSN, APRN-BC, AOCN®, Ali McBride,(2) PharmD, MS, BCPS, BCOP, Hollie Devine,(3) MSN, ANP-BC, Charise Gleason,(4) MSN, NP-BC, AOCNP®, and Sandra Kurtin,(5) RN, MSN, AOCN®, ANP-C, on behalf of the International Myeloma Foundation Nurse Leadership Board
Prescriber's Corner
Monoclonal Antibodies in the Treatment of Multiple Myeloma
Charise Gleason,(1) MSN, NP-BC, AOCNP®, Hollie Devine,(2) MSN, ANP-BC, Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, Deborah Doss,(4) RN, OCN®, and Sandra Kurtin,(5) RN, MSN, AOCN®, ANP-C, on behalf of the International Myeloma Foundation Nurse Leadership Board
Grand Rounds
Updates in the Diagnosis and Monitoring of Multiple Myeloma
Sandra Kurtin,(1) RN, MSN, AOCN®, ANP-C, Page Bertolotti,(2) RN, BSN, OCN®, Kevin Brigle,(3) PhD, NP, and Daniel Verina,(4) BS, BSN, MSN, ACNP-BC, on behalf of the International Myeloma Foundation Nurse Leadership Board
Practice Matters
Adherence, Persistence, and Treatment Fatigue in Multiple Myeloma
Sandra Kurtin,(1) RN, MSN, AOCN®, ANP-C, Kathleen Colson,(2) RN, BSN, BS, Joseph Tariman,(3) PhD, ANP-BC, Beth Faiman,(4) PhD, MSN, APRN-BC, AOCN®, and Elizabeth Finley-Oliver,(5) RN, BSN, OCN, on behalf of the International Myeloma Foundation Nurse Leadership Board
Tools and Technology
Resources for Patients and Caregivers With Multiple Myeloma and Their Providers
Kevin Brigle, PhD, NP, on behalf of The International Myeloma Foundation Nurse Leadership Board
Appendix
Multiple Myeloma Treatment Options for Newly Diagnosed, Relapsed, and Refractory Disease
Kimberly Noonan,(1) RN, ANP, AOCN®, Teresa S. Miceli,(2) RN, BSN, OCN®, Patricia Mangan,(3) RN, MSN, APRN-BC, and Sandra Rome,(4) RN, MN, AOCN®, CNS, on behalf of the International Myeloma Foundation Nurse Leadership Board
Continuing Education
Continuing Education Information

Meeting Report
Meet The Panel

Meeting Abstract
Methotrexate and Fluorouracil Toxicities: What Advanced Practitioners in Oncology Need to Know

Meeting Abstract
Case Studies: Collaborative Practice In Action

Meeting Abstract
Questions Answered About Glucarpidase

Meeting Abstract
Questions Answered About Uridine Triacetate

Continuing Education
Continuing Education Information

Editorial
Collaborative Practice Enhances Supportive Care in Cancer: Chemotherapy-Induced Nausea and Vomiting
Rita Wickham, PhD, RN, AOCN® Sally Barbour, PharmD, BCOP, CPP Teresa Scardino, RPA-C, MPAS
Review Article
Risks for Chemotherapy-Induced Nausea and Vomiting: Capturing Relevant Data
Teresa Scardino, RPA-C, MPAS
Review Article
Actualizing Standards of Care for Chemotherapy-Induced Nausea and Vomiting
Sally Barbour, PharmD, BCOP, CPP
Review Article
Managing Chemotherapy-Induced Nausea and Vomiting: Past, Present, and Future
Rita Wickham, PhD, RN, AOCN®
Grand Rounds
Managing Chemotherapy-Induced Nausea and Vomiting: An Adaptable, Collaborative Approach for a Patient With Colon Cancer
Rita Wickham, PhD, RN, AOCN®, Sally Barbour, PharmD, BCOP, CPP, and Teresa Scardino, RPA-C, MPAS
Review Article
Relapsed or Relapsed/Refractory Multiple Myeloma
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Prescriber's Corner
Carfilzomib
J. Michael Vozniak, PharmD, BCOP
Review Article
The Side Effect Profile of Carfilzomib: From Clinical Trials to Clinical Practice
Laura McBride, RN, BSN, OCN®, CCRP, and Christine O. Samuel, RN, BSN, OCN®, CCRP
Grand Rounds
Treatment of Patients With Multiple Myeloma: A Relapsed and Refractory Case Study
Sandra E. Kurtin, RN, MS, AOCN®, ANP-C
Review Article
Treatment With Carfilzomib: A Promising Future for Multiple Myeloma
Donna Catamero, ANP-BC, OCN®, CCRC, and Charise Gleason, MSN, ANP, AOCNP®
Continuing Education
Continuing Education Information

Review Article
Monitoring, Treatment Resistance, and Treatment Failure in CML: Breaking Barriers to Improved Outcomes
Jorge Eduardo Cortes, MD(1). John M. Goldman, DM, FRCP, FRCPath, FMedSci(2), and Timothy P. Hughes, MD, MBBS(3); Faculty Perspectives by Patricia S. Ault, RN, FNP(1), and Mary Beth Rios, CCRP, RN(1)
Continuing Education
Continuing Education Information

Editorial
Managing Hematologic Malignancies: The Balancing Act
Sandra Kurtin, RN, MS, AOCN®, ANP-C
Review Article
Current Approaches to the Diagnosis and Management of Myelodysplastic Syndromes
Sandra Kurtin, RN, MS, AOCN®, ANP-C
Review Article
Risk Stratification and Management of Acute Myeloid Leukemia
Jean A. Ridgeway, MSN, APN, NP-C, AOCN®
Review Article
Update on the Management of Follicular Lymphomas
Amy Goodrich, MSN, CRNP
Review Article
Management of Multiple Myeloma and Serious Side Effects
Elizabeth Bilotti, MSN, RN, APN, OCN®
Continuing Education
Continuing Education Information

Review Article
Oral Mucositis: Addressing the Causes, Challenges, and Clinical Management
Carrie F. Daly, MS, RN, AOCN®, and Annette M. Quinn, MSN, RN